IL-2 in the tumor microenvironment is necessary for Wiskott-Aldrich syndrome protein deficient NK cells to respond to tumors in vivo.
Sci Rep
; 6: 30636, 2016 08 01.
Article
in En
| MEDLINE
| ID: mdl-27477778
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Killer Cells, Natural
/
Interleukin-2
/
Wiskott-Aldrich Syndrome Protein
/
Tumor Microenvironment
/
Lymphoma
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Sci Rep
Year:
2016
Document type:
Article
Affiliation country:
Sweden
Country of publication:
United kingdom